尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Franchini Indrani Lall, Responsable de la Conformité. Insider active across 4 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 9 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €673k. Activity tracked since 8 June 2021. The latest transaction was disclosed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Indrani Lall Franchini is the Executive Vice President and Chief Compliance Officer at ALEXION PHARMACEUTICALS, INC. She is responsible for regulatory compliance and risk management. Franchini brings valuable expertise, contributing to the company's sustainability and reputation.